Hear the unique perspective of Worldwide’s oncology experts about the evolution of clinical trials due to COVID-19 and why those changes matter.
Authors:
Mireille Cantarini, BSc, MB, ChB, MRCP, FFPM
Senior Medical Director, Medical Affairs, Oncology
Clare Wallis
President of Oncology Business Unit
